Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Ben3
    Member
    • Sep 2022
    • 79

    #1

    Did anyone visit ASHG 2022? And what are your highlights?

    Did anyone here attend the American Society of Human Genetics (ASHG) Annual Meeting this year? I'm very sad I wasn't able to go and it seems I missed a lot of interesting announcements and technologies. I was hoping to hear about some of the events that took place because there isn't summary that I could find for the conference.

    A few things I have been able to find:


    - It looks like PacBio was showing off it's two new (long- and short-read sequencers).

    - Oxford Nanopore debuted their PromethION 2 Solo and gave a seminar.

    - There was a lot of interesting research done on different ethnicities across the world. I can find the abstracts, but don't have any way to watch the presentations.

    - Illumina gave some talks and so did many smaller but interesting biotech companies.

    - Even Complete Genomics (MGI/BGI) has shown off a few of their sequencers to be released in the US. I'm super curious about what this means for the US market and what labs will switch from Illumina over to this platform.

    So did anyone go? And what are some of your highlights?!

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...